Propanc Biopharma, Inc. (PPCB)
NASDAQ: PPCB · Real-Time Price · USD
1.470
-0.010 (-0.68%)
At close: Jun 23, 2026, 4:00 PM EDT
1.403
-0.067 (-4.56%)
After-hours: Jun 23, 2026, 5:31 PM EDT
Propanc Biopharma Market Cap
Propanc Biopharma has a market cap or net worth of $1.23 million as of June 23, 2026. Its market cap has decreased by -96.22% in one year.
Market Cap
1.23M
Enterprise Value
1.37M
1-Year Change
-96.22%
Ranking
Category
Stock Price
$1.47
Market Cap Chart
Since February 10, 2023, Propanc Biopharma's market cap has increased from $571.43K to $1.23M, an increase of 115.07%. That is a compound annual growth rate of 25.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 23, 2026 | 1.23M | -82.86% |
| Dec 31, 2025 | 7.17M | 4,231.28% |
| Dec 31, 2024 | 165.57K | -48.84% |
| Dec 29, 2023 | 323.62K | -43.37% |
| Feb 10, 2023 | 571.43K | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| VivoSim Labs | 3.31M |
| Virax Biolabs Group | 3.20M |
| GRI Bio | 3.18M |
| Calidi Biotherapeutics | 3.04M |
| Oragenics | 2.66M |
| Bone Biologics | 2.40M |
| Biodexa Pharmaceuticals | 2.05M |
| Valion Bio | 1.66M |